Equine Encephalomyelitis Outbreak in Argentina: Symptoms, Prevention, and Vaccine Shortage

Equine Encephalomyelitis Outbreak in Argentina: Symptoms, Prevention, and Vaccine Shortage

The head of the Zoonosis Program of the Salta Ministry of Health, Nicolás Ruiz, stated that in Salta there are no vaccines to prevent equine encephalomyelitis, a disease that was detected in horses in the provinces of Corrientes and Santa Fe on November 25, when officially The first cases were confirmed. As of yesterday afternoon, … Read more

Why is the MMR Vaccine Known as a Triple Viral Vaccine?

Why is the MMR Vaccine Known as a Triple Viral Vaccine?

The MMR vaccine is known for its triple viral combination that protects against diseases such as measles, mumps and rubella, and is given in a two-dose series. Triple viral vaccine against measles, rubella and mumps According to the Colombian vaccination scheme, the triple viral vaccine is applied in two doses: the first between 12 and … Read more

Bluetongue Vaccination Begins in Murcia Region After Detection of Three Cases in Águilas

Bluetongue Vaccination Begins in Murcia Region After Detection of Three Cases in Águilas

Vaccination against bluetongue begins in the Region after detecting three cases in ÁguilasEFE / Juan Herrero The Community has detected cases of blue tongue in three livestock farms in Águilaswhich is why it has “immediately” launched the action protocol to prevent its spreadwhich involves measures such as disinfestation of farms, limitation of movements and vaccination … Read more

IFV: Cuba’s Leading Biotechnology Institution and Vaccine Production Plant

IFV: Cuba’s Leading Biotechnology Institution and Vaccine Production Plant

“I have great confidence in the production capacity and quality of the production of that plant, since it is already the third,” said the commander in chief, Fidel Castro, at the opening ceremony of the facility on December 3. of 1993. The IFV, a research, development and production entity, was founded in 1991 after a … Read more

Mexico’s Cofepris Reports Delays in COVID-19 Vaccine Authorization Process

Mexico’s Cofepris Reports Delays in COVID-19 Vaccine Authorization Process

The Federal Commission for the Protection against Health Risks (Cofepris) reported this Wednesday that the pharmaceutical companies that requested the health register of vaccines contra COVID-19 require more time to provide information to obtain authorization for your Commercial use. Through a statement, the regulatory authority pointed out that Pfizer SA de CVvaccine producer Comirnaty; y … Read more

Future of Cancer Vaccines: Market Growth and Technological Advances

Future of Cancer Vaccines: Market Growth and Technological Advances

Unfortunately, cancer is a disease that affects more and more people. But, fortunately, this health problem has more and more treatments and positive results. Advances in medicine are increasingly important and help patients improve and recover. The treatments are also… Unfortunately, cancer is a disease that affects more and more people. But, fortunately, this health … Read more

The Risk of Myocarditis and Pericarditis After Covid Vaccine Administration: Evidence and Studies

The Risk of Myocarditis and Pericarditis After Covid Vaccine Administration: Evidence and Studies

There is more and more evidence – and it is beginning to be publicly known three years into the pandemic – about the risk of suffering myocarditis or pericarditis after the administration of the Covid vaccine. That is, inflammation of the heart muscle or the membrane that surrounds it. An adverse effect that appears after … Read more

Winter Season Vaccination Campaign: Influenza, Covid, and Pneumococcus Protection in Durango 2024

Winter Season Vaccination Campaign: Influenza, Covid, and Pneumococcus Protection in Durango 2024

During the winter season considered from October 16 to March 31, 2024, three vaccines will be applied to protect the population from Acute Respiratory Infections; Influenza, Covid and Pneumococcus, the first of them contemplates greater coverage in the state with a goal of 149,900 doses for the entire health sector, although to date there is … Read more

Novavax in Europe: Interview with Jörgen Persson, Vice President of Market Access and Customer Engagement

Novavax in Europe: Interview with Jörgen Persson, Vice President of Market Access and Customer Engagement

Gema Maldonado (Uppsala, Sweden)At the Novavax plant in the Swedish city of Uppsala, where it manufactures Matrix-M, the adjuvant for its Covid-19 vaccine and the new malaria vaccine approved by the World Health Organization (WHO), the Vice President of Market Access and Customer Engagement at Novavax in Europe, Jörgen Perssonhas granted an interview to Sanity … Read more

The vaccination plan with Patria fails; is not ready | The universal

The vaccination plan with Patria fails;  is not ready |  The universal

President Andrés Manuel López Obrador and the director of National Council of Humanities, Sciences and Technologies (Conahcyt), María Elena Álvarez-Buyllathey committed that the Mexican Patria vaccine would begin to be produced starting in September and would even be applied starting last month in the national anti-Covid-19 campaign; However, the biological is not yet ready. Currently, … Read more